# Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs

> **NCT07161635** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Alcon Research** · enrollment: 110 (actual)

## Conditions studied

- Aphakia
- Presbyopia

## Interventions

- **DEVICE:** Clareon PanOptix Pro/Pro Toric Trifocal IOL
- **PROCEDURE:** Phacoemulsification

## Key facts

- **NCT ID:** NCT07161635
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-10-14
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07161635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07161635, "Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07161635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*